跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Stugeron - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Stugeron
Approved
STANDARD
Stugeron
Janssen Korea Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
dbd2776bab3d58f8
Company
Janssen Korea Ltd.
Type
Standard
Approval Details
Approval Id
dbd2776bab3d58f8
Drug Approval Philippines Name
Stugeron
Product Name
Stugeron
Registration Number
DR-XY34825
Brand Name
Stugeron
Generic Name
Cinnarizine
Dosage Form
Tablet
Dosage Strength
25 mg
Manufacturer
Janssen Korea Ltd.
Importer
Johnson & Johnson (Philippines), Inc.
Distributor
Zuellig Pharma Corp.
Company Detail Path
/organization/janssen-korea-ltd
Issuance Date
08 July 2023
Expiry Date
20 August 2028
Pharmacologic Category
Anti-vertigo
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
dbd2776bab3d58f8
Type
Standard
Back to Philippines FDA Approvals